Evonik stock rejects BASF talks as takeover pressure builds

Published on 10/31/2026 at 10:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evonik stock faced renewed takeover pressure after its board declined formal talks with BASF. The company still left room for a confidential exchange.

Takeover pressure shapes Evonik week

Evonik's executive board declined to enter formal takeover negotiations with BASF.
The company left room for a confidential exchange about BASF's rationale and strategic case.
Evonik's next scheduled quarterly results are due on November 3, 2026.

Evonik, DE000EVNK013, Illustration mit AI erstellt.

Evonik's executive board has rejected formal takeover negotiations with BASF, keeping the German chemicals group on an independent course while leaving limited room for further contact. The decision was announced on Friday, October 30, 2026, in an Evonik statement.

Board keeps strategic independence

Evonik said it had reviewed a letter from BASF dated October 22 concerning a possible voluntary public takeover offer. On the information available, the executive board decided not to enter negotiations and said it remained focused on the company's strategic direction and further development as an independent business.

The decision does not close every channel. Evonik is willing to hold a purely informational and confidential exchange so it can explain its position and BASF can outline the rationale and key considerations behind its interest. That leaves the strategic question open without creating formal deal talks.

Results add a near-term catalyst

Evonik is scheduled to publish its third-quarter results on Tuesday, November 3, 2026. The report will give investors a fresh basis for assessing operating performance while the takeover discussion remains unresolved.

The real-time quote of Evonik stock traded at 21.07 euros on Lang & Schwarz at 10:48 CET on Saturday, October 31, 2026.